The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
New research reveals that combining bimagrumab and semaglutide enhances fat loss while preserving muscle mass, revolutionizing obesity treatment strategies.
HMGCR inhibitors were found to significantly increase the risk of experiencing microvascular complications in patients with diabetes, while NPC1L1 inhibitors were found to reduce the risk.